Affinity Biologicals Inc. (Affinity) was founded in 1987 by the principals Hugh and Patricia Hoogendoorn. With a strong background in hemostasis research and a focus on reagent development, Affinity has become a primary manufacturer of more than 250 reagents and kits used in hemostasis and thrombosis research and diagnostics. Our product line includes: coagulation related antibodies, matched-pair antibody sets for ELISA, depleted/deficient plasmas, protease inhibitor deficient plasmas, the VisuLize line of complete ELISA kits and the VisuCon & VisuCal coagulation controls and calibration plasmas. All Affinity Biologicals products are manufactured in our Ancaster, ON (Canada) facility, products are sold direct in North America and world wide through a network of branded and private-label distributors.
Affinity has an ISO 13485:2003 registered Quality System and is a licensed medical device manufacturer recognized by the US Food and Drug Administration, Health Canada and European regulatory authorities (CE Mark).
Over the years, Affinity has built key affiliations with:
- The Thrombosis & Atherosclerosis Research Insititute (TaARI)
- McMaster University
- Queen’s University
- Hemostasis Reference Laboratory